immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Alimentare correttamente un animale epilettico

Bibliografia

1. Berk BA, Packer RMA, Law TH, Volk HA. Investigating owner use of dietary supplements in dogs with idiopathic epilepsy. Res Vet. Sci. 2018;119:276-284.

2. Carrasco MC, Vallejo JR, Pardo-de-Santayana M, Peral D, Martín MA, Altimiras J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother. Res. 2009 Dec;23(12):1795-1796.

3. Eyres L, Eyres MF, Chisholm A, Brown RC. Coconut oil consumption and cardiovascular risk factors in humans. Nutrition reviews. 2016 Apr 1;74(4):267-280.

4. Ferreira A, Rodrigues M, Fortuna A, Falcao A, Alves G. Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: an in vitro evaluation with focus on antiepileptic drugs. Food Res. Int. 2018;103:110-120.

5. Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP, UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia 2017;58(9):1586-1592.

6. Hand M, Thatcher C, Remillard R. Small animal clinical nutrition. 5th ed Novotny. June 2010:1314p.

7. Kaplan JS, Stella N, Catterall WA, Westenbroek RE. Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proc. Natl. Acad. Sci. USA. 2017;114(42):11229-11234.

8. Kearsley-Fleet L, O’Neill DG, Volk HA, Church DB, Brodbelt DC. Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Vet. Rec. 2013;172:338.

9. Lane SB, Bunch SE. Medical management of recurrent seizures in dogs and cats. J. of Vet. Inter. Med. 1990;4:26-39.

10. Law TH et coll. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy. British J. of Nutrition. 2015;114(09):1438-1447.

11. Leuschner J, Müller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract. Arzneimittelforschung. 1993 Jun;43(6):638-641.

12. Lujan ASS, Anderson TK. The role of diet in refractory canine epilepsy: a retrospective case series. Abstract of the BSAVA Congress, Quedgeley, UK. Scientific Proceedings 2004:53.

13. Matthews H, Granger N, Wood J, Skelly B. Effects of essential fatty acid supplementation in dogs with idiopathic epilepsy: a clinical trial. Vet. J. 2012;191:396-398.

14. Patterson EE, Muñana KK, Kirk CA, et coll. Results of a ketogenic food trial for dogs with idiopathic epilepsy. J. Vet. Intern. Med. 2005;1:421.

15. Taha AY, Burnham WM, Auvin S. Polyunsaturated fatty acids and epilepsy. Epilepsia, 2010;51:1348-1358.

16. Torres-Hernandez BA, Del Valle-Mojica LM, Ortiz JG. Valerenic acid and Valeriana officinalis extracts delay onset of Pentylenetetrazole (PTZ)- induced seizures in adult Danio rerio (Zebrafish). BMC Complement. Altern. Med. 2015;15:228.

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
05/02/2021

L’interesse dei trigliceridi a catena media nei cani epilettici

Riguardo all’epilessia, diverse pubblicazioni scientifiche menzionano i vantaggi dei trigliceridi a catena media nel controlloclinico, in aggiunta o addirittura in sostituzione dei normali antiepilettici. Questo interesse è in crescita in quanto la terapia abituale è associata a effetti avversi clinicamente significativi come sedazione, polifagia, polidipsia, persino atassia, inoltre biologicamente promuove l’induzione di enzimi epatici che provoca, a lungo termine, l’insorgenza di epatopatie. Un recente studio valuta l’impatto dell’integrazione con trigliceridi a catena media nella gestione dei cani con epilessia e monitora la frequenza e la gravità degli effetti collaterali.

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo